Flow cytometric crossmatching and outcome one year after renal transplantation
Previous studies have shown that flow cytometric cross match assays can identify an at risk population in renal transplantation [1–5]. We used the assay for recipient selection for 1 year. Recipients with donor T cell directed IgG were excluded from transplantation and those with B cell directed IgG were treated with increased immunosuppressant. The transplants performed over this period (n = 126) were compared with an earlier series (n = 118) in which flow cytometric cross match results did not influence patient management. The results were evaluated for mortality and graft outcome at 3 months and 1 year. In addition, postoperative complications and duration of hospital stay were also assessed.